IMAX IMAX CORP
Photographic Equipment & Supplies · NYSE · SEC CIK 921582 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY28.1%
TTM net income YoY239.0%
TTM EPS YoY232.4%
Revenue 3-yr CAGR7.8%
Net income 3-yr CAGR74.1%
Margins
Gross margin63.5%
Operating margin26.8%
Net margin27.7%
FCF margin30.2%
EBITDA margin42.0%
Returns
ROE31.9%
ROA14.0%
ROIC (approx.)52.9%
Asset turnover0.50x
Leverage & solvency
Liabilities / assets42.7%
Debt / equity0.00x
Current ratio—
Interest coverage17.45x
Cash quality & payout
Operating cash flow / net income1.13x
Accruals ratio-1.8%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $410.21M | $352.21M |
| Cost of revenue | $164.02M | $162.01M |
| Gross profit | $246.19M | $190.20M |
| R&D expense | $5.82M | $5.10M |
| SG&A expense | $138.46M | $132.70M |
| Operating income | $84.23M | $43.86M |
| Interest expense | $7.36M | $8.08M |
| Pretax income | $63.29M | $37.70M |
| Income tax | $17.77M | $5.00M |
| Net income | $34.88M | $26.06M |
| EBITDA | $146.68M | $109.36M |
| EPS (basic) | 0.65 | 0.49 |
| EPS (diluted) | 0.63 | 0.48 |
| Weighted avg. shares (diluted) | 55.54M | 53.86M |
| Balance sheet | ||
| Cash & equivalents | $151.17M | $100.59M |
| Receivables | $108.08M | $107.67M |
| Inventory | $32.51M | $32.84M |
| PP&E, net | $242.91M | $240.13M |
| Goodwill | $45.81M | $52.81M |
| Intangibles | $32.39M | $35.12M |
| Total assets | $894.03M | $830.40M |
| Total liabilities | $466.30M | $452.18M |
| Shareholders' equity | $337.89M | $299.47M |
| Shares outstanding | 53.92M | 52.95M |
| Cash flow statement | ||
| Operating cash flow | $127.07M | $70.84M |
| Capital expenditure | $8.17M | $8.43M |
| Free cash flow | $118.90M | $62.41M |
| Investing cash flow | -$41.92M | -$41.22M |
| Financing cash flow | -$34.08M | -$6.04M |
| Depreciation & amortization | $62.45M | $65.50M |
| Stock-based compensation | $26.60M | $22.80M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.